跳至主要内容
临床试验/NCT03839511
NCT03839511已完成不适用

Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study

Pennington Biomedical Research Center1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2018年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4
试验地点
1
主要终点
Peak Epinephrine Levels

研究概览

简要总结

A hyperinsulinemic-hypoglycemic clamp is an experimental procedure, which allows for hypoglycemia to be studied in a safe and controlled manner. The goal of this study is to establish the hyperinsulinemic-hypoglycemic clamp procedure at Pennington Biomedical Research Center in order to apply the knowledge gained to future studies which will determine the efficacy of our biomarker for predicting susceptibility to hypoglycemia. Additionally, our use of continuous glucose monitoring (CGM) during the clamp procedure will provide novel data regarding the accuracy of CGM during hypoglycemic conditions in a controlled research setting.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male or female
  • Ages 18-40 years
  • BMI between 20 kg/m2 and 30 kg/m2 (±0.5 kg/m2 will be accepted)
  • Medically cleared for participation in the study

排除标准

  • History of clinically diagnosed diabetes or a fasting blood glucose >126 mg/dL
  • Average screening blood pressure >140/90 mmHg
  • History of cardiovascular disease
  • Pregnant, planning to become pregnant, or breastfeeding
  • Based on the investigative team's clinical judgement, a subject may not be appropriate for participation in the study.

结局指标

主要结局

Peak Epinephrine Levels

时间窗: 90 minute interval following initiation of insulin infusion

This value represents the average peak epinephrine value measured during the hypoglycemic clamp procedure

次要结局

  • CGM Glucose(90 minute interval following initiation of insulin infusion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David McDougal

Assistant Professor

Pennington Biomedical Research Center

研究点 (1)

Loading locations...

相似试验